Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Small peptide ALK-3 agonist demonstrates regenerative potential in kidney

March 29, 2012

Nymox reports new data from follow-up study of NX-1207

March 28, 2012

Astellas Pharma files MAA for new fixed-dose combination tablet for LUTS

March 27, 2012

EMA to review Vivus' MAA for avanafil in ED

March 26, 2012

Novel mineralocorticoid receptor antagonists presented by KBP BioSciences

March 15, 2012

FDA accepts CRTX-080 NDA for filing

March 14, 2012

KBP BioSciences reports new mineralocorticoid receptor antagonists

March 8, 2012

Scientists in Brazil identify new phosphodiesterase 5 inhibitors

March 8, 2012

Phase II trial of CTP-499 advances

March 7, 2012

Solabegron demonstrates efficacy in phase II study

Feb. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...